What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Major depressive disorder
- Psychiatry
Andrew A. Nierenberg mainly focuses on Psychiatry, Major depressive disorder, Depression, Internal medicine and Bipolar disorder.
The study incorporates disciplines such as Randomized controlled trial and Clinical psychology in addition to Psychiatry.
The concepts of his Major depressive disorder study are interwoven with issues in Venlafaxine, Citalopram, STAR*D and Anesthesia.
His Depression research is multidisciplinary, relying on both Severity of illness, Risk factor and Rating scale.
His Internal medicine research is multidisciplinary, incorporating elements of Placebo and Endocrinology.
His Bipolar disorder research incorporates themes from Prevalence of mental disorders, Substance abuse and Major depressive episode.
His most cited work include:
- Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report (2853 citations)
- Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice (2525 citations)
- Sequenced treatment alternatives to relieve depression (STAR * D): rationale and design (828 citations)
What are the main themes of his work throughout his whole career to date?
Andrew A. Nierenberg focuses on Psychiatry, Depression, Bipolar disorder, Major depressive disorder and Internal medicine.
His Psychiatry research includes elements of Randomized controlled trial and Clinical psychology.
His Depression research incorporates elements of Pharmacotherapy, Clinical trial, Pediatrics and Rating scale.
His Bipolar disorder research focuses on Mood and how it connects with Mood disorders.
His Major depressive disorder study deals with Venlafaxine intersecting with Mirtazapine.
His research integrates issues of Gastroenterology, Placebo and Endocrinology in his study of Internal medicine.
He most often published in these fields:
- Psychiatry (56.98%)
- Depression (35.24%)
- Bipolar disorder (30.54%)
What were the highlights of his more recent work (between 2015-2021)?
- Bipolar disorder (30.54%)
- Psychiatry (56.98%)
- Depression (35.24%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Bipolar disorder, Psychiatry, Depression, Internal medicine and Clinical psychology.
The Bipolar disorder study combines topics in areas such as Quetiapine, Lithium, Randomized controlled trial and Mood.
His Psychiatry study frequently links to other fields, such as Disease.
His Internal medicine study incorporates themes from Major depressive disorder, Antidepressant and Rating scale.
The various areas that he examines in his Major depressive disorder study include Behavioral medicine and Placebo.
The study incorporates disciplines such as Logistic regression, Anxiety, Suicidal ideation, Severity of illness and Comorbidity in addition to Clinical psychology.
Between 2015 and 2021, his most popular works were:
- Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study (146 citations)
- Testing a machine-learning algorithm to predict the persistence and severity of major depressive disorder from baseline self-reports (101 citations)
- Testing a machine-learning algorithm to predict the persistence and severity of major depressive disorder from baseline self-reports (101 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
